Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00875563
Other study ID # 04-541
Secondary ID 370015, FNCT
Status Completed
Phase N/A
First received February 19, 2009
Last updated March 7, 2016
Start date January 2005
Est. completion date September 2015

Study information

Verified date March 2016
Source Cook
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The Zenith(R) Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date September 2015
Est. primary completion date February 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm

Exclusion Criteria:

- Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal

- Renal artery stenosis greater than 50 percent

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Zenith(R) Fenestrated AAA Endovascular Graft
The Zenith(R) Fenestrated AAA Endovascular Graft with the H&L-B One-Shot™ Introduction System is indicated for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms having morphology suitable for endovascular repair

Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts
United States University of North Carolina Chapel Hill North Carolina
United States Cleveland Clinic Cleveland Ohio
United States Shands Hospital Gainesville Florida
United States The Indiana Heart Hospital Indianapolis Indiana
United States Dartmouth Hitchcock Medical Center Lebanon New Hampshire
United States NYU Medical Center New York New York
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania
United States Mayo Clinic Rochester Minnesota
United States University of California, San Francisco San Francisco California
United States Harborview Medical Center Seattle Washington
United States Barnes-Jewish Hospital St. Louis Missouri
United States University of Massachusetts Worcester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Cook

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Treatment Success Technical success (successful access, deployment, and patency of the Fenestrated Graft, and patency of all vessels targeted by a fenestration intra-operatively), and freedom from the following: type I or type III endoleaks, AAA-related serious adverse events, AAA-related major complications, and aneurysm enlargement greater than 0.5 cm.
A serious adverse event is defined as any occurrence of death, aneurysm rupture, or conversion to open surgical repair.
A major complication is defined as any occurrence of Q-wave myocardial infarction, congestive heart failure, cardiac ischemia requiring intervention, renal failure requiring permanent dialysis, bowel obstruction, ischemia, or fistula, stroke with permanent deficit, or paralysis.
6 months Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02888613 - Mini-laparotomy Versus Mini Lumbotomy N/A
Recruiting NCT00662480 - Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark Phase 4
Terminated NCT00372138 - Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms N/A
Completed NCT00989729 - Preoperative Methylprednisolone in Endovascular Aortic Repair N/A
Active, not recruiting NCT02345005 - Iliac Branch Excluder ReGistry (IceBERG)
Completed NCT01390740 - Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
Completed NCT00833924 - Zenith(R) Low Profile AAA Endovascular Graft Clinical Study N/A
Terminated NCT00610090 - Safety Study for the Treatment of Abdominal Aortic Aneurysms Phase 2
Completed NCT02477111 - European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
Recruiting NCT01538056 - Physician Modified Endovascular Grafts N/A
Completed NCT01106391 - A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) N/A
Terminated NCT00444821 - The (PIVOTAL) Study N/A
Completed NCT01599533 - Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm N/A
Completed NCT01328197 - Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms Phase 1
Completed NCT00705718 - Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System N/A
Completed NCT02125890 - Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms Phase 3
Completed NCT02048514 - The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms N/A
Terminated NCT00546013 - Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome N/A
Recruiting NCT05004051 - ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Withdrawn NCT03965364 - China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)